OEM News

ECG Devices from Aerotel Medical Systems Receive CE Mark Approval

The two investigational devices are not available for sale in the United States.

By: Michael Barbella

Managing Editor

Aerotel Medical Systems has obtained CE Mark approval for its HeartView P12/8i and HeartView 12L electrocardiography (ECG) devices, which feature advanced technology to provide capability for high-resolution ECG recordings with immediate transmission capability via the mobile network.

HeartView P12/8i is an ECG event recorder-transmitter for personal use, while HeartView 12L is a high-resolution 12-lead ECG recorder and transmitter designed for professional use.

HeartView P12/8i features high-resolution 12-lead ECG recording technology specifically designed for patient use.

The HeartView P12/8i and HeartView 12L ECG devices automatically transmit the recorded ECG through Bluetooth to Aerotel’s Mobile CliniQ App. The ECG data is then automatically sent from the mobile device to a cardiac call center for immediate diagnosis.

The HeartView devices allow diagnosis of cardiac symptoms, remote monitoring of chronic heart patients, recording and transmission of an ECG to a cardiac call center, and cardiac analysis for clinical studies.

“The two new mobile devices are aimed at improving patients’ quality of life, enabling people who previously had to remain in the hospital to get on with their normal lives,” Aerotel president and CEO David Rubin said.

HeartView P12/8i and HeartView 12L are investigational devices in the United States and therefore not available for sale.

Aerotel Medical Systems is a global manufacturer of modular, mobile and home based telemedicine and telecare solutions.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters